This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

J.P. Morgan Biotech Analyst Meacham Exits for New Barclays Gig

09/08/14 - 08:48 AM EDT

J.P. Morgan Biotech Analyst Meacham Exits for New Barclays Gig Meacham is taking a new job at Barclays where he will cover biotech and pharma stocks.

READ FULL POST

Google Healthcare Startup Calico Partners With Abbvie

09/03/14 - 01:19 PM EDT

Google Healthcare Startup Calico Partners With Abbvie Under the agreement, Calico and Abbvie will work together to discover and develop new drugs for age-related diseases, including neuro-degeneration and cancer.

READ FULL POST

Sunesis Takes a Run Through the Feuerstein-Ratain Rule

09/02/14 - 10:29 AM EDT

Sunesis Takes a Run Through the Feuerstein-Ratain Rule Results from Sunesis' phase III study in acute myeloid leukemia should be released this month or next.

READ FULL POST

Biotech Stock Boom Times Are Back

08/26/14 - 07:00 AM EDT

Biotech Stock Boom Times Are Back The iShares Nasdaq Biotechnology ETF closed at 272.63 Monday, less than one point below the year (and all-time) closing high reached on Feb. 25.

READ FULL POST

Galena Fires CEO Ahn, Offers No Parting Gifts

08/25/14 - 08:48 AM EDT

Galena Fires CEO Ahn, Offers No Parting Gifts CEOs who leave companies on good terms get cushy severance packages. Galena's Ahn did not.

READ FULL POST

Ampio: The Freezer Killed My Osteoarthritis Drug

08/21/14 - 10:23 AM EDT

Ampio: The Freezer Killed My Osteoarthritis Drug Ampio Pharmaceuticals is blaming a mini Polar Vortex for blowing up a pivotal study of its osteoarthritis drug Ampion.

READ FULL POST

Northwest Bio Can't Keep Its DC-Vax Claims Straight

08/14/14 - 10:20 AM EDT

Northwest Bio Can't Keep Its DC-Vax Claims Straight Contradictory statements made on whether or not Northwest Bio conducted an interim analysis of its DC-Vax phase III study.

READ FULL POST